EP Patent

EP1211294A1 — Improved process and method for the preparation of asymmetric monofunctionalised indocyanine labelling reagents and obtained compounds

Assigned to Visen Medical Inc · Expires 2002-06-05 · 24y expired

What this patent protects

A process for preparing an asymmetrical indocyanine dye characterised in that it comprises the steps of: a) reacting a first quaternised indolenine or substituted indolenine with a compound of the formula (II) or hydrochloride thereof, wherein n is 0 or 1 Ph is phenyl …

USPTO Abstract

A process for preparing an asymmetrical indocyanine dye characterised in that it comprises the steps of: a) reacting a first quaternised indolenine or substituted indolenine with a compound of the formula (II) or hydrochloride thereof, wherein n is 0 or 1 Ph is phenyl or substituted phenyl X is hydrogen, halogen or alkyl, preferably chlorine, in a solvent selected from the group consisting of acetic acid, acetic anhydride and mixtures thereof in the presence of acetyl chloride, to obtain an intermediate hemicyanine, and b) further reacting said intermediate hemicyanine with a second quaternised indolenine or substituted indolenine different from said first indolenine.

Drugs covered by this patent

Patent Metadata

Patent number
EP1211294A1
Jurisdiction
EP
Classification
Expires
2002-06-05
Drug substance claim
No
Drug product claim
No
Assignee
Visen Medical Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.